Epigenetic Modifications and Their Role in Cancer Progression

Abstract

Important epigenetic alterations that regulate gene expression without changing DNA sequence include DNA methylation, histone modifications, and non-coding RNA regulation. By impacting oncogene activation and tumor suppressor gene silencing, these alterations are being more and more acknowledged as critical drivers of tumor genesis, development, and metastasis in cancer biology. Genomic instability and unchecked cell proliferation are caused by aberrant DNA methylation patterns, which include promoter-specific hypermethylation and global hypomethylation. Similarly, a malignant environment can be established through histone changes like as acetylation, methylation, and phosphorylation, which change the structure of chromatin and affect transcriptional activity. MicroRNAs and long non-coding RNAs, in particular, shape cancer progression by regulating pathways that control cell cycle, apoptosis, and invasion. Epigenetic medicines, including inhibitors of DNA methyltransferase and histone deacetylase, have demonstrated promise in clinical settings, and the reversible character of epigenetic alterations has opened new pathways for therapeutic intervention.